FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+86.2%
5Y CAGR+61.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+86.2%/yr
Annual compound
5Y CAGR
+61.7%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
11.1x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $7.41M | +64.5% |
| 2024 | $4.50M | +90.2% |
| 2023 | $2.37M | +106.5% |
| 2022 | $1.15M | +120.2% |
| 2021 | $521000.00 | -22.1% |
| 2020 | $669000.00 | - |